APA (7th ed.) Citation

Chen, R., Lin, Q., Zhu, Y., Shen, Y., Xu, Q., Tang, H., . . . Li, X. (2023). Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children. Orphanet Journal of Rare Diseases, 18(1), 1. https://doi.org/10.1186/s13023-023-02861-9

Chicago Style (17th ed.) Citation

Chen, Ruyue, et al. "Sintilimab Treatment for Chronic Active Epstein–Barr Virus Infection and Epstein–Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Children." Orphanet Journal of Rare Diseases 18, no. 1 (2023): 1. https://doi.org/10.1186/s13023-023-02861-9.

MLA (9th ed.) Citation

Chen, Ruyue, et al. "Sintilimab Treatment for Chronic Active Epstein–Barr Virus Infection and Epstein–Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Children." Orphanet Journal of Rare Diseases, vol. 18, no. 1, 2023, p. 1, https://doi.org/10.1186/s13023-023-02861-9.